361 related articles for article (PubMed ID: 26234760)
21. The Gut-Liver Axis in Cholestatic Liver Diseases.
Blesl A; Stadlbauer V
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33801133
[TBL] [Abstract][Full Text] [Related]
22. Role of bile acids in the gut-liver axis.
Schneider KM; Albers S; Trautwein C
J Hepatol; 2018 May; 68(5):1083-1085. PubMed ID: 29519549
[No Abstract] [Full Text] [Related]
23. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
[TBL] [Abstract][Full Text] [Related]
24. Obesity-Linked Gut Microbiome Dysbiosis Associated with Derangements in Gut Permeability and Intestinal Cellular Homeostasis Independent of Diet.
Nagpal R; Newman TM; Wang S; Jain S; Lovato JF; Yadav H
J Diabetes Res; 2018; 2018():3462092. PubMed ID: 30250849
[TBL] [Abstract][Full Text] [Related]
25. The Gut Microbiota as a Mediator of Metabolic Benefits after Bariatric Surgery.
Anhê FF; Varin TV; Schertzer JD; Marette A
Can J Diabetes; 2017 Aug; 41(4):439-447. PubMed ID: 28552651
[TBL] [Abstract][Full Text] [Related]
26. The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation.
van Best N; Jansen PL; Rensen SS
Hepatol Int; 2015 Jul; 9(3):406-15. PubMed ID: 26067771
[TBL] [Abstract][Full Text] [Related]
27. The Local Defender and Functional Mediator: Gut Microbiome.
Yang H; Duan Z
Digestion; 2018; 97(2):137-145. PubMed ID: 29310114
[TBL] [Abstract][Full Text] [Related]
28. Emerging pathogenic links between microbiota and the gut-lung axis.
Budden KF; Gellatly SL; Wood DL; Cooper MA; Morrison M; Hugenholtz P; Hansbro PM
Nat Rev Microbiol; 2017 Jan; 15(1):55-63. PubMed ID: 27694885
[TBL] [Abstract][Full Text] [Related]
29. Molecular Physiology of Bile Acid Signaling in Health, Disease, and Aging.
Perino A; Demagny H; Velazquez-Villegas L; Schoonjans K
Physiol Rev; 2021 Apr; 101(2):683-731. PubMed ID: 32790577
[TBL] [Abstract][Full Text] [Related]
30. The joint power of sex and stress to modulate brain-gut-microbiota axis and intestinal barrier homeostasis: implications for irritable bowel syndrome.
Pigrau M; Rodiño-Janeiro BK; Casado-Bedmar M; Lobo B; Vicario M; Santos J; Alonso-Cotoner C
Neurogastroenterol Motil; 2016 Apr; 28(4):463-86. PubMed ID: 26556786
[TBL] [Abstract][Full Text] [Related]
31. Prebiotic effects: metabolic and health benefits.
Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
[TBL] [Abstract][Full Text] [Related]
32. Gut microbiome as a therapeutic target for liver diseases.
Singh TP; Kadyan S; Devi H; Park G; Nagpal R
Life Sci; 2023 Jun; 322():121685. PubMed ID: 37044173
[TBL] [Abstract][Full Text] [Related]
33. Gut microbiota, obesity and diabetes.
Patterson E; Ryan PM; Cryan JF; Dinan TG; Ross RP; Fitzgerald GF; Stanton C
Postgrad Med J; 2016 May; 92(1087):286-300. PubMed ID: 26912499
[TBL] [Abstract][Full Text] [Related]
34. Gut-liver axis at the frontier of host-microbial interactions.
Brandl K; Kumar V; Eckmann L
Am J Physiol Gastrointest Liver Physiol; 2017 May; 312(5):G413-G419. PubMed ID: 28232456
[TBL] [Abstract][Full Text] [Related]
35. Microbiome Disturbances and Autism Spectrum Disorders.
Rosenfeld CS
Drug Metab Dispos; 2015 Oct; 43(10):1557-71. PubMed ID: 25852213
[TBL] [Abstract][Full Text] [Related]
36. The gut microbiota and the metabolic health of the host.
Joyce SA; Gahan CG
Curr Opin Gastroenterol; 2014 Mar; 30(2):120-7. PubMed ID: 24468803
[TBL] [Abstract][Full Text] [Related]
37. Gut microbiota in chronic kidney disease.
Cigarran Guldris S; González Parra E; Cases Amenós A
Nefrologia; 2017; 37(1):9-19. PubMed ID: 27553986
[TBL] [Abstract][Full Text] [Related]
38. The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention.
Jones ML; Martoni CJ; Ganopolsky JG; Labbé A; Prakash S
Expert Opin Biol Ther; 2014 Apr; 14(4):467-82. PubMed ID: 24479734
[TBL] [Abstract][Full Text] [Related]
39. Relationship between Gut Microbiota, Gut Hyperpermeability and Obesity.
Gasmi A; Mujawdiya PK; Pivina L; Doşa A; Semenova Y; Benahmed AG; Bjørklund G
Curr Med Chem; 2021; 28(4):827-839. PubMed ID: 32693755
[TBL] [Abstract][Full Text] [Related]
40. Gut-organ axis: a microbial outreach and networking.
Ahlawat S; Asha ; Sharma KK
Lett Appl Microbiol; 2021 Jun; 72(6):636-668. PubMed ID: 32472555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
